Patrick O'Donnell
Direktor/Vorstandsmitglied bei CHITOGENX INC.
Vermögen: - $ am 30.04.2024
Profil
Patrick T.
O'Donnell is the founder of ProteoThera, Inc. He currently holds the position of President & Chief Executive Officer at HD Lifesciences LLC, is President, Chief Executive Officer & Director at NanoHive Medical LLC, and is an Independent Director at ChitogenX, Inc. In the past, he served as President, Chief Executive Officer & Director at Histogenics Corp., President & Chief Executive Officer at ProChon Biotech Ltd., Director-Global Marketing at Confluent Surgical, Inc., and EVP & GM-Commercial Operations at BONESUPPORT HOLDING AB.
He holds an MBA degree from Dominican University (Illinois) and an undergraduate degree from the University of Wisconsin.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CHITOGENX INC
-.--% | 09.11.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Patrick O'Donnell
Unternehmen | Position | Beginn |
---|---|---|
CHITOGENX INC. | Direktor/Vorstandsmitglied | 24.02.2021 |
HD Lifesciences LLC | Vorstandsvorsitzender | 01.01.2021 |
NanoHive Medical LLC
NanoHive Medical LLC Information Technology ServicesTechnology Services NanoHive Medical LLC is a leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company is based in Woburn, MA. The company's proprietary biomimetic Soft Titanium™ technology sets them apart in the $1.50B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration, all of which lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive was founded by Chris Jones and Ian Helmar, and the CEO is Patrick T. O'Donnell. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Patrick O'Donnell
Unternehmen | Position | Ende |
---|---|---|
ProChon Biotech Ltd.
ProChon Biotech Ltd. Pharmaceuticals: MajorHealth Technology ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel. | Vorstandsvorsitzender | 01.05.2011 |
Confluent Surgical, Inc.
Confluent Surgical, Inc. Medical SpecialtiesHealth Technology Confluent Surgical, Inc. designed and developed medical devices. The company was founded by Farhad Khosravi in August 1998 and was headquartered in Waltham, MA. | Vertrieb & Marketing | - |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Vorstandsvorsitzender | - |
BONESUPPORT HOLDING AB | Geschäftsführer | - |
OCUGEN, INC. | Präsident | 10.06.2013 |
Ausbildung von Patrick O'Donnell
Dominican University (Illinois) | Masters Business Admin |
University of Wisconsin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BONESUPPORT HOLDING AB | Health Technology |
CHITOGENX INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Confluent Surgical, Inc.
Confluent Surgical, Inc. Medical SpecialtiesHealth Technology Confluent Surgical, Inc. designed and developed medical devices. The company was founded by Farhad Khosravi in August 1998 and was headquartered in Waltham, MA. | Health Technology |
Histogenics Corp.
Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
ProChon Biotech Ltd.
ProChon Biotech Ltd. Pharmaceuticals: MajorHealth Technology ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel. | Health Technology |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Health Technology |
HD Lifesciences LLC | |
NanoHive Medical LLC
NanoHive Medical LLC Information Technology ServicesTechnology Services NanoHive Medical LLC is a leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company is based in Woburn, MA. The company's proprietary biomimetic Soft Titanium™ technology sets them apart in the $1.50B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration, all of which lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive was founded by Chris Jones and Ian Helmar, and the CEO is Patrick T. O'Donnell. | Technology Services |